Rocuronium Bromide Patent Expiration

Rocuronium Bromide was first introduced by Organon Usa Inc in its drug Zemuron on Mar 17, 1994. Another drug containing Rocuronium Bromide is Rocuronium Bromide. 23 different companies have introduced drugs containing Rocuronium Bromide.


Rocuronium Bromide Patents

Given below is the list of patents protecting Rocuronium Bromide, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

NEW
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Rocuronium Bromide US11998605 Stabilized Aqueous Compositions Of Neuromuscular Blocking Agents Jul 22, 2039 B Braun Medical



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Rocuronium Bromide's patents.

Given below is the list recent legal activities going on the following patents of Rocuronium Bromide.

Activity Date Patent Number
Patent litigations
Electronic Review 07 Jun, 2024 US11998605
Patent eGrant Notification 04 Jun, 2024 US11998605
Recordation of Patent Grant Mailed 04 Jun, 2024 US11998605
Email Notification 04 Jun, 2024 US11998605
Patent Issue Date Used in PTA Calculation 04 Jun, 2024 US11998605
Recordation of Patent eGrant 04 Jun, 2024 US11998605
Mail Patent eGrant Notification 04 Jun, 2024 US11998605
Email Notification 16 May, 2024 US11998605
Issue Notification Mailed 15 May, 2024 US11998605
Dispatch to FDC 29 Apr, 2024 US11998605


Rocuronium Bromide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Rocuronium Bromide Generic API Manufacturers

Several generic applications have been filed for Rocuronium Bromide. The first generic version for Rocuronium Bromide was by Hospira Inc and was approved on Nov 26, 2008. And the latest generic version is by Aspiro Pharma Ltd and was approved on Mar 4, 2026.

Given below is the list of companies who have filed for Rocuronium Bromide generic, along with the locations of their manufacturing plants worldwide.